JNJ
Johnson & Johnson
- Operating cash flow, FY2025
- $24.5B
- YoY, FY2025
- +1.1%
- 5-year CAGR
- +0.8%
- 10-year CAGR
- +2.3%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| FY2025 | $24.5B | +1.1% |
| FY2024 | $24.3B | +6.5% |
| FY2023 | $22.8B | +7.5% |
| FY2022 | $21.2B | −9.5% |
| FY2021 | $23.4B | −0.5% |
| FY2020 | $23.5B | +0.5% |
| FY2019 | $23.4B | +5.5% |
| FY2018 | $22.2B | +5.4% |
| FY2017 | $21.1B | +12.2% |
| FY2016 | $18.8B | −4.1% |
| FY2015 | $19.6B | +4.6% |
| FY2014 | $18.7B | +7.4% |
| FY2013 | $17.4B | +13.1% |
| FY2012 | $15.4B | +7.7% |
| FY2011 | $14.3B | −12.7% |
| FY2010 | $16.4B | −1.1% |
| FY2009 | $16.6B | +10.7% |
| FY2008 | $15.0B | −0.3% |
| FY2007 | $15.0B | — |